Filing Details
- Accession Number:
- 0001225208-11-014156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-05-12 18:45:49
- Reporting Period:
- 2011-05-10
- Filing Date:
- 2011-05-12
- Accepted Time:
- 2011-05-12 18:45:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1346102 | E John Celentano | 345 Park Avenue New York NY 10154 | Svp Hr Public Affairs & Philan | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Acquisiton | 2011-05-12 | 136,955 | $28.63 | 250,440 | No | 4 | M | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2011-05-12 | 14,084 | $28.63 | 236,356 | No | 4 | F | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2011-05-12 | 22,800 | $28.53 | 213,556 | No | 4 | S | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2011-05-12 | 102,706 | $28.63 | 110,850 | No | 4 | F | Direct | |
Common Stock, $0.10 Par Value | Disposition | 2011-05-10 | 3,700 | $28.81 | 0 | No | 4 | S | Indirect | By BMY Savings & Investment Program |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Indirect | By BMY Savings & Investment Program |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2011-05-12 | 52,474 | $28.63 | 52,474 | $17.51 |
Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2011-05-12 | 26,148 | $28.63 | 26,148 | $22.14 |
Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2011-05-12 | 58,333 | $24.74 | 58,333 | $24.74 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
52,475 | 2019-03-02 | No | 4 | M | Direct | |
26,149 | 2018-03-03 | No | 4 | M | Direct | |
58,334 | 2016-11-30 | No | 4 | M | Direct |
Footnotes
- Shares withheld for payment of taxes and fees upon exercise of stock options.
- This transaction was executed in multiple trades from $28.5900 to 28.6800 . The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades ranging from $28.5200 to $28.5450. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security hold of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares withheld for payment of exercise price upon exercise of stock options.
- The reporting person directed the Trustee of the Savings and Investment Plan to sell 3,700.298 shares of Bristol-Myers Squibb common stock held in the Bristol-Myers Squibb Company stock fund.
- Twenty-five percent of the stock option award vests on each of the first, second, third and fourth anniversaries of the grant date, which was March 3, 2009.
- Twenty-five percnet of the stock option award vest on each of the first, second, third, and fourth anniversaries of the grant date, which was March 4, 2008.
- One-third of the stock option award vest on the third, fourth, and fifth anniversary of the grant date, which was December 1, 2006.